Gene · 54541
Papers3,069
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 3,069
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Apoptosis Evaluation in Circulating CD34+-Enriched Hematopoietic Stem and Progenitor Cells in Patients with Abnormally Increased Production of Endogenous Glucocorticoids in Course of Cushing's Syndrome. | Int J Mol Sci | 2022 | 36555435 | PubTator, text mining | PubMed |
| Characterization of Transcriptomic and Proteomic Changes in the Skin after Chronic Fluocinolone Acetonide Treatment. | Biomolecules | 2022 | 36551249 | PubTator, text mining | PubMed |
| Cellular features of localized microenvironments in human meniscal degeneration: a single-cell transcriptomic study. | Elife | 2022 | 36548025 | PubTator, text mining | PubMed |
| New insights into the interplay between autophagy and cartilage degeneration in osteoarthritis. | Front Cell Dev Biol | 2022 | 36544901 | PubTator, text mining | PubMed |
| Single-cell transcriptomics reveals cell type-specific immune regulation associated with anti-NMDA receptor encephalitis in humans. | Front Immunol | 2022 | 36544777 | PubTator, text mining | PubMed |
| Identification of key genes of anti-programmed death ligand 1 for meningioma immunotherapy by bioinformatic analysis. | Med Oncol | 2022 | 36538194 | PubTator, text mining | PubMed |
| Endoplasmic reticulum stress-mediated cell death in liver injury. | Cell Death Dis | 2022 | 36535923 | PubTator, text mining | PubMed |
| Circular RNA-related CeRNA network and prognostic signature for patients with oral squamous cell carcinoma. | Front Pharmacol | 2022 | 36532732 | PubTator, text mining | PubMed |
| Autoencoder Networks Decipher the Association between Lung Cancer and Alzheimer's Disease. | Comput Intell Neurosci | 2022 | 36518809 | PubTator, text mining | PubMed |
| Biological and pharmacological roles of m6A modifications in cancer drug resistance. | Mol Cancer | 2022 | 36517820 | PubTator, text mining | PubMed |
Integrating Pharmacogenomics Data-Driven Computational Drug Prediction with Single-Cell RNAseq to Demonstrate the Efficacy of a NAMPT Inhibitor against Aggressive, Taxane-Resistant, and Stem-like Cells in Lethal Prostate Cancer. | Cancers (Basel) | 2022 | 36497496 | PubTator, text mining | PubMed |
| New Insights into Mechanisms of Ferroptosis Associated with Immune Infiltration in Neonatal Hypoxic-Ischemic Brain Damage. | Cells | 2022 | 36497037 | PubTator, text mining | PubMed |
| Metabolic reprogramming by miRNAs in the tumor microenvironment: Focused on immunometabolism. | Front Oncol | 2022 | 36483029 | PubTator, text mining | PubMed |
| Coexpression network analysis of human candida infection reveals key modules and hub genes responsible for host-pathogen interactions. | Front Genet | 2022 | 36482897 | PubTator, text mining | PubMed |
| Treatment patterns and unmet needs in adults with classic congenital adrenal hyperplasia: A modified Delphi consensus study. | Front Endocrinol (Lausanne) | 2022 | 36465641 | PubTator, text mining | PubMed |
| β-(4-fluorobenzyl) Arteannuin B induced interaction of ATF-4 and C/EBPβ mediates the transition of breast cancer cells from autophagy to senescence. | Front Oncol | 2022 | 36465376 | PubTator, text mining | PubMed |
| METTL4-mediated nuclear N6-deoxyadenosine methylation promotes metastasis through activating multiple metastasis-inducing targets. | Genome Biol | 2022 | 36461076 | PubTator, text mining | PubMed |
| LncRNA ELF3-AS1 inhibits gastric cancer by forming a negative feedback loop with SNAI2 and regulates ELF3 mRNA stability via interacting with ILF2/ILF3 complex. | J Exp Clin Cancer Res | 2022 | 36457025 | PubTator, text mining | PubMed |
| A circadian rhythm-related biomarker for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma. | Aging (Albany NY) | 2022 | 36455876 | PubTator, text mining | PubMed |
| System analysis based on the ER stress-related genes identifies WFS1 as a novel therapy target for colon cancer. | Aging (Albany NY) | 2022 | 36445321 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54541/papers?page=31